...
首页> 外文期刊>Trends in anaesthesia and critical care >Heart rate as a predictor and a therapeutic target of cardiac ischemic complications after non-cardiac surgery. A narrative review
【24h】

Heart rate as a predictor and a therapeutic target of cardiac ischemic complications after non-cardiac surgery. A narrative review

机译:心率作为非心脏病后心脏病缺血性并发症的预测因子和治疗靶标。 叙述评论

获取原文
获取原文并翻译 | 示例

摘要

Postoperative cardiac ischemic complications are frequent and strongly associated with postoperative mortality. Elevated heart rate before, during and after surgery increases the risk of postoperative myocardial injury, myocardial infarction and mortality. Yet, in absence of strong causal evidence, heart rate is seldom used for risk stratification. While beta-blockers reduce the risk of tachycardia and myocardial infarction, their initiation within 24 h of surgery is harmful. Rather than a "one-size fits all" approach, we propose that safe and efficient administration of beta blockers should take into account both the periop-erative risk and the pharmacogenetic profile of each patient In the future, new drugs designed to modulate heart rate without significant hypotension (e.g. ivabradine) may replace beta-blockers.
机译:术后心脏缺血性并发症频繁,与术后死亡率密切相关。 心率升高,手术期间和后,术后术后心肌损伤,心肌梗死和死亡率的风险增加。 然而,在没有强烈的因果证据的情况下,心率很少用于风险分层。 虽然β受体阻滞剂降低心动过速和心肌梗塞的风险,但他们在24小时内的起始是有害的。 而不是“单尺寸适合所有”方法,我们提出安全有效的β受体阻滞剂施用应考虑到未来每位患者的过敏性风险和药物发生概况,新的药物旨在调节心率 没有显着的低血压(例如IVabradine)可以取代β-嵌体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号